Market Place
Sourcing Support
Affini-T to Present Data on Oncogenic Driver Programs at SITC
06 Nov 2024 //
BUSINESSWIRE
Affini-T: First Patient Dosed In KRAS G12V Trial, ASCO 2024 Presentation
28 May 2024 //
BUSINESSWIRE
Affini-T: KRAS, TP53 Preclinical Data At ASGCT Annual Meeting
01 May 2024 //
BUSINESSWIRE
Affini-T Presents Preclinical Data at the AACR Annual Meeting 2024
07 Apr 2024 //
BUSINESSWIRE
Affini-T to Present Preclinical Data from its Programs Targeting KRAS G12D
13 Mar 2024 //
BUSINESSWIRE
Affini-T to Present at the 42nd Annual J.P. Morgan Healthcare Conference
07 Jan 2024 //
BUSINESSWIRE
Affini-T Appoints Healthcare Capital Markets Veteran Kathy Bergsteinsson as CFO
13 Nov 2023 //
BUSINESSWIRE
Affini-T Therapeutics to Present Preclinical Gene Editing Data from KRAS G12D
31 Oct 2023 //
BUSINESSWIRE
Affini-T plans to go public in 2024
25 Jul 2023 //
FIERCE BIOTECH
Affini-T to close Seattle lab as it concentrates in Boston
20 Jul 2023 //
ENDPTS
Affini-T taps Sanofi alum to lead hunt for partnerships; Alkermes locks in CEO
02 Jun 2023 //
ENDPTS
Affini-T Appoints Industry Veteran Thaminda Ramanayake as Chief Business Officer
02 Jun 2023 //
BUSINESSWIRE
Affini-T to Present AFNT-211 T Cell Product Attributes Targeting KRAS G12V
25 May 2023 //
BUSINESSWIRE
Affini-T Therapeutics to Present Novel CRISPR Gene Editing Data from Oncogenic
09 May 2023 //
BUSINESSWIRE
Affini-T Presents Data from its Oncogenic Driver Program at AACR
13 Apr 2023 //
BUSINESSWIRE
Affini-T to Present at the 41st Annual J.P. Morgan Healthcare Conference
05 Jan 2023 //
BUSINESSWIRE
ElevateBio and Affini-T partner on KRAS therapies; Casma raises $46M
15 Nov 2022 //
ENDPTS
Affini-T Therapeutics to Present Data from Lead Programs Targeting KRAS G12V
07 Nov 2022 //
BUSINESSWIRE
Affini-T Therapeutics Named to the 2022 Endpoints 11
22 Sep 2022 //
BUSINESSWIRE
Affini-T Therapeutics Appoints Dirk Nagorsen, M.D., as CMO
26 Jul 2022 //
BUSINESSWIRE
Affini-T Therapeutics Appoints Jill DeSimone to its Board of Directors
12 Jul 2022 //
BUSINESSWIRE
Affini-T & Metagenomi Announce Next-Generation Gene Editing Partnership
15 Jun 2022 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.